World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
22364
World Ranking
2892
National Ranking
1364

Overview

Randy A. Albrecht is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on medicine with substantial engagement in immunology and microbiology. Within these broad fields, their subfields of study include infectious diseases, epidemiology, immunology, molecular biology, and agronomy and crop science.

Their work covers a range of topics related to viral infections and immune responses. Key areas of research include influenza virus studies, investigations on SARS-CoV-2 and COVID-19, clinical research related to COVID-19, respiratory viral infections, interferon and immune responses, animal disease management, epidemiology, and the broader immune response and inflammation.

Randy A. Albrecht has contributed extensively to scientific literature, with frequent publications appearing in several research venues. The most common platforms for their work include bioRxiv (Cold Spring Harbor Laboratory), Nature, Nature Communications, Emerging Microbes & Infections, and the Journal of Virology.

Some of their recent publications include:

  • "Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19" (2020), published in Cell
  • "Animal models for COVID-19" (2020), published in Nature
  • "Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing" (2020), published in Nature
  • "A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics" (2021), published in Nature Biomedical Engineering
  • "Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience" (2021), published in Modern Pathology

Throughout their career, Randy A. Albrecht has frequently collaborated with various researchers. Notable co-authors include Adolfo García-Sastre, Wen-Chun Liu, Michael Schotsaert, Raveen Rathnasinghe, and Florian Krammer.

Best Publications

  • Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

    Daniel Blanco-Melo;Benjamin E. Nilsson-Payant;Wen Chun Liu;Skyler Uhl

  • Programming the magnitude and persistence of antibody responses with innate immunity.

    Sudhir Pai Kasturi;Ioanna Skountzou;Randy A. Albrecht;Dimitrios Koutsonanos

  • Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I

    Michaela Ulrike Gack;Randy Allen Albrecht;Tomohiko Urano;Tomohiko Urano;Kyung-Soo Inn;Kyung-Soo Inn

  • Meta- and Orthogonal Integration of Influenza “OMICs” Data Defines a Role for UBR4 in Virus Budding

    Shashank Tripathi;Marie O. Pohl;Yingyao Zhou;Ariel Rodriguez-Frandsen

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

    Laura Riva;Shuofeng Yuan;Xin Yin;Laura Martin-Sancho

  • Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination

    Salah Eddine Bentebibel;Santiago Lopez;Gerlinde Obermoser;Nathalie Schmitt

  • Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes

    Monique Gannagé;Dorothee Dormann;Randy Albrecht;Jörn Dengjel

  • Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency

    Michael J. Ciancanelli;Sarah X.L. Huang;Priya Luthra;Hannah Garner

  • Transcription Elongation Can Affect Genome 3D Structure.

    Sven Heinz;Lorane Texari;Michael G.B. Hayes;Matthew Urbanowski

  • Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus

    Carole R. Baskin;Helle Bielefeldt-Ohmann;Terrence M. Tumpey;Patrick J. Sabourin

  • A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.

    Longlong Si;Haiqing Bai;Melissa Rodas;Wuji Cao

  • Suppression of the antiviral response by an influenza histone mimic

    Ivan Marazzi;Jessica S. Y. Ho;Jaehoon Kim;Balaji Manicassamy

  • Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 Protein

    Ricardo Rajsbaum;Randy A. Albrecht;May K. Wang;Natalya P. Maharaj

  • Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes

    Rong Hai;Florian Krammer;Gene S. Tan;Natalie Pica

  • Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.

    John Steel;Anice C. Lowen;Lindomar Pena;Matthew Angel

  • Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission

    Unknown

  • Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody Rearrangements

    Katherine J.L. Jackson;Katherine J.L. Jackson;Yi Liu;Krishna M. Roskin;Jacob Glanville

  • A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses

    Shashank Tripathi;Vinod R. M. T. Balasubramaniam;Julia A. Brown;Ignacio Mena

  • Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host

    Andrew Varble;Randy A. Albrecht;Simone Backes;Marshall Crumiller

  • Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.

    Clare Bryce;Zachary Grimes;Elisabet Pujadas;Sadhna Ahuja

  • Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses

    I. Margine;F. Krammer;R. Hai;N. S. Heaton

Frequent Co-Authors

Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai
Florian Krammer
Florian Krammer Icahn School of Medicine at Mount Sinai
Peter Palese
Peter Palese Icahn School of Medicine at Mount Sinai
Stuart C. Sealfon
Stuart C. Sealfon Icahn School of Medicine at Mount Sinai
Robert Sebra
Robert Sebra Icahn School of Medicine at Mount Sinai
Benjamin R. tenOever
Benjamin R. tenOever Icahn School of Medicine at Mount Sinai
Donald E. Ingber
Donald E. Ingber Harvard University
Sumit K. Chanda
Sumit K. Chanda Discovery Institute
Virginia Pascual
Virginia Pascual Cornell University
Christopher Benner
Christopher Benner University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Many students begin with foundational programs such as an easiest absn to get into, which offers a fast track to becoming a Registered Nurse (RN). This path provides a strong clinical background valuable in immunology research and patient care.

Another accessible option includes the easiest lpn programs to get into, allowing entry into nursing with less time and a more flexible schedule. Licensed Practical Nurses play critical roles in supporting immunological health environments, especially in community and long-term care settings.

For advanced practice, pursuing the easiest np program can lead to becoming a Nurse Practitioner. This role often involves patient education and managing care plans related to immunology conditions, making it a vital link between research and clinical application.

Specializing further, mental health nursing ties closely with immunological health. Programs recognized among the best pmhnp programs provide strong clinical placements for Psychiatric Mental Health Nurse Practitioners, who address the psychological impacts connected with immune system disorders.

Best Scientists Citing Randy A. Albrecht

Trending Scientists